76155-56-1
10-[(3-Amino-2,36,-trideoxy- -L-arabino-hexopyranosyl)oxy]-8-[(1S)-1,2-dihydroxyethyl]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-(8S,10S)-5,12-naphthacenedione
Epidoxorubicino
13-dihydro-4'-epidoxorubicin
Epidoxorubicinol
Various Metabolites and Impurities
Metabolites & Impurities
(8S)-10α-[(3-Amino-2,3,6-trideoxy-α-L-arabino-hexopyranosyl)oxy]-8-[(S)-1,2-dihydroxyethyl]-6,8α,11-trihydroxy-7,8,9,10-tetrahydro-1-methoxy-5,12-naphthacenedione
4'-epi-Doxorubicinol
Epirubicinol, 60% (Contains Unknown Salts)
(Mixture of DiastereoMers)
Inhibitor
Intermediates & Fine Chemicals
Pharmaceuticals
10-[(3-AMino-2,36,-trideoxy-α-L-arabino-hexopyranosyl)oxy]-8-[(1S)-1,2
-dihydroxyethyl]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-Methoxy-(8S,10S)-5,12-naphthacenedione Hydrochloride
13-DihydroadriaMycin Hydrochloride
4'-EpiadriaMycinol
NSC 268238
NSC 268710
10-[(3-AMino-2,36,-trideoxy-α-L-arabino-hexopyranosyl)oxy]-8-[(1S)-1,2
-dihydroxyethyl]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-Methoxy-(8S,10S)-5,12-naphthacenedione Citrate
13-DihydroadriaMycin Citrate
Epirubicinol
(Mixture of DiastereoMers)
|